Testosterone Cypionate

Beginner First Cycle (Harm Reduction)

Conservative beginner AAS cycle for harm reduction: testosterone-only at moderate dose with on-cycle HCG and post-cycle Nolvadex. Designed to minimise risk while providing meaningful data about individual response to testosterone before adding other compounds.

Test Cyp 300mg/week (lower than community 500mg — harm reduction dose).

Beginner Test-Only Blast + PCT

12-week testosterone cypionate blast at beginner doses with on-cycle HCG for testicular maintenance, followed by a 2-week clearance window and 4-week Nolvadex PCT. The gold-standard first cycle.

Blast and Cruise

Alternating between a blast (supraphysiological testosterone dose for 8–16 weeks) and a cruise (return to TRT dose indefinitely). Avoids the PCT phase entirely. Common among experienced TRT users and advanced bodybuilders who do not intend to discontinue testosterone.

Blast phase: beginner blast protocol 300–500mg/week for 12 weeks.

Daily SubQ Micro-Dose TRT

Testosterone cypionate administered daily subcutaneously at low volume (0.1–0.15mL/day). Produces the most stable serum testosterone and oestradiol levels of any injectable protocol, closely mimicking the natural circadian rhythm. Favoured by those sensitive to hormonal fluctuations.

Daily micro-dose SubQ. Typical total weekly dose 70–140mg split 7 ways.

Low-Dose Testosterone — Non-Binary / Microdose

Testosterone cypionate or enanthate at micro-dose (typically 20–50mg/week) for non-binary, genderqueer, or transmasculine individuals seeking partial masculinisation. Lower doses produce selective changes — increased libido and clitoral growth typically first; voice changes and significant hair growth require higher doses and longer duration.

Transmasc T Cyp microdose protocol 20–50mg/week.

Standard TRT Protocol

Evidence-based testosterone replacement with HCG for testicular maintenance and optional low-dose aromatase inhibitor. The most common TRT stack recommended by progressive clinicians.